Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review

References

• LombardiAGrimaldiAZappavignaSMissoGCaragliaMHepatocarcinoma: genetic and epigenetic featuresMinerva Gastroenterol Dietol2018641142728398025
   PubMed Web of Science ®Google Scholar
• BosettiCTuratiFLa VecchiaCHepatocellular carcinoma epidemiologyBest Pract Res Clin Gastroenterol201428575377025260306
   PubMed Web of Science ®Google Scholar
• GüthleMDollingerMMEpidemiología y factores de riesgo de carcinoma hepatocelular. [Epidemiology and risk factors of hepatocellular carcinoma]Radiologe2014547654659 German24973122
   PubMedGoogle Scholar
• WangPKangDCaoWWangYLiuZDiabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysisDiabetes Metab Res Rev201228210912221898753
   PubMed Web of Science ®Google Scholar
• ChuangSCLeeYCWuGJStraifKHashibeMAlcohol consumption and liver cancer risk: a meta-analysisCancer Causes Control20152691205123126134046
   PubMed Web of Science ®Google Scholar
• LeeYCCohetCYangYCStaynerLHashibeMStraifKMeta-analysis of epidemiologic studies on cigarette smoking and liver cancerInt J Epidemiol20093861497151119720726
   PubMed Web of Science ®Google Scholar
• CalleEERodriguezCWalker-ThurmondKThunMJOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adultsN Engl J Med2003348171625163812711737
   PubMed Web of Science ®Google Scholar
• WilliamsJHPhillipsTDJollyPEStilesJKJollyCMAggarwalDHuman aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventionsAm J Clin Nutr20048051106112215531656
   PubMed Web of Science ®Google Scholar
• NoureddinMRinellaMENonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinomaClin Liver Dis201519236137925921668
   PubMed Web of Science ®Google Scholar
• YuJShenJSunTTZhangXWongNObesity, insulin resistance, NASH and hepatocellular carcinomaSemin Cancer Biol2013236 Pt B48349123876851
   PubMed Web of Science ®Google Scholar
• HuangYCaiXQiuMPrediabetes and the risk of cancer: a meta-analysisDiabetologia201457112261226925208757
   PubMed Web of Science ®Google Scholar
• KasmariAJWelchALiuGLeslieDMcGarrityTRileyTIndependent of cirrhosis, hepatocellular carcinoma risk is increased with diabetes and metabolic syndromeAm J Med20171306746.e174746
   PubMed Web of Science ®Google Scholar
• DyalHKAguilarMBartosGDiabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic reviewDig Dis Sci201661263664526703125
   PubMed Web of Science ®Google Scholar
• LaiMSHsiehMSChiuYHChenTHType 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infectionHepatology20064361295130216729295
   PubMed Web of Science ®Google Scholar
• ChenCLYangHIYangWSMetabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in TaiwanGastroenterology2008135111112118505690
   PubMed Web of Science ®Google Scholar
• WangCSYaoWJChangTTWangSTChouPThe impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statusesCancer Epidemiol Biomarkers Prev20091872054206019549812
   PubMed Web of Science ®Google Scholar
• KoWHChiuSYYangKCChenHHDiabetes, hepatitis virus infection and hepatocellular carcinoma: a case-control study in hepatitis endemic areaHepatol Res201242877478122469194
   PubMed Web of Science ®Google Scholar
• DersimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• LiQLiWWYangXType 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis BInt J Cancer201213151197120222052244
   PubMed Web of Science ®Google Scholar
• FuSCHuangYWWangTCHuJTChenDSYangSSIncreased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort studyAliment Pharmacol Ther201541111200120925846548
   PubMed Web of Science ®Google Scholar
• HsiangJCGaneEJBaiWWGerredSJType 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patientsJ Gastroenterol Hepatol201530359159925250942
   PubMed Web of Science ®Google Scholar
• El-SeragHBMasonACRisk factors for the rising rates of primary liver cancer in the United StatesArch Intern Med2000160213227323011088082
   PubMedGoogle Scholar
• SasazukiSCharvatHHaraADiabetes mellitus and cancer risk: pooled analysis of eight cohort studies in JapanCancer Sci2013104111499150723889822
   PubMed Web of Science ®Google Scholar
• Starup-LindeJKarlstadOEriksenSACARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysisCurr Drug Saf20138529633224215312
   PubMedGoogle Scholar
• KingLYKhaliliHHuangESDiabetes mellitus is associated with an increased risk of HCC in a large prospective cohort with long term follow-upHepatology201460281A
   Web of Science ®Google Scholar
• ChenJHanYXuCXiaoTWangBEffect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studiesEur J Cancer Prev2015242899924809655
   PubMed Web of Science ®Google Scholar
• CholankerilGPatelRKhuranaSSatapathySKHepatocellular carcinoma in non-alcoholic steatohepatitis: current knowledge and implications for managementWorld J Hepatol201791153354328469809
   PubMed Web of Science ®Google Scholar
• ZhengZZhangCYanJDiabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic areaPLoS One2013812e8477624386416
   PubMed Web of Science ®Google Scholar
• HungC-HLeeC-MWangJ-HImpact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapyInt J Cancer2011128102344235220669224
   PubMed Web of Science ®Google Scholar
• AraseYKobayashiMSuzukiFEffect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis CHepatology201357396497322991257
   PubMed Web of Science ®Google Scholar
• HassanMMHwangLYHattenCJRisk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitusHepatology20023651206121312395331
   PubMed Web of Science ®Google Scholar
• WelzelTMGraubardBIQuraishiSPopulation-attributable fractions of risk factors for hepatocellular carcinoma in the United StatesAm J Gastroenterol201310881314132123752878
   PubMed Web of Science ®Google Scholar
• FarrellGInsulin resistance, obesity, and liver cancerClin Gastroenterol Hepatol201412111711923954644
   PubMed Web of Science ®Google Scholar
• BalkauBKahnHSCourbonDEschwègeEDucimetièrePParis Prospective StudyHyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris prospective studyDiabetes Care200124584384911347741
   PubMed Web of Science ®Google Scholar
• BabaHTsuneyamaKHyperinsulinemia rather than hyperglycemia can accelerate the progression of hepatocellular carcinomaHepatology201591 Suppl 1S318S19
   Google Scholar
• MooreMAParkCBTsudaHImplications of the hyperinsulinaemia-diabetes-cancer link for preventive effortsEur J Cancer Prev199872891079818771
   PubMed Web of Science ®Google Scholar
• TanakaSMohrLSchmidtEVSugimachiKWandsJRBiological effects of human insulin receptor substrate-1 overexpression in hepatocytesHepatology19972635986049303488
   PubMed Web of Science ®Google Scholar
• LongatoLde La MonteSKuzushitaNOverexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liverHepatology20094961935194319475691
   PubMed Web of Science ®Google Scholar
• AmpueroJRomero-GomezMPrevention of hepatocellular carcinoma by correction of metabolic abnormalities: role of statins and metforminWorld J Hepatol2015781105111126052399
   PubMedGoogle Scholar
• FarrellGCLarterCZNonalcoholic fatty liver disease: from steatosis to cirrhosisHepatology2006432 Suppl 1S99S11216447287
   PubMed Web of Science ®Google Scholar
• KawamuraYIkedaKAraseYDiabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitisJ Gastroenterol Hepatol200823111739174618713301
   PubMed Web of Science ®Google Scholar
• TingCTChenRCChenCCLiuMHChuDKuoNWDiabetes worsens the surgical outcomes in cirrhotic patients with hepatocellular carcinomaTohoku J Exp Med20122271738122688467
   PubMed Web of Science ®Google Scholar
• TateishiROkanoueTOkitaKP572 insulin use is related to the development of hepatocellular carcinoma at younger age with non-viral etiologyJ Hepatol2014601S260
   PubMed Web of Science ®Google Scholar
• BosettiCFranchiMNicotraFInsulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databasesPharmacoepidemiol Drug Saf201524777177826013675
   PubMed Web of Science ®Google Scholar
• ZhangXHarmsenWSMettlerTAContinuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetesHepatology20146062008201624798175
   PubMed Web of Science ®Google Scholar
• DonadonVBalbiMMasMDCasarinPZanetteGMetformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver diseaseLiver Int201030575075820331505
   PubMed Web of Science ®Google Scholar